Alterations of red blood cell shape and sialic acid membrane content in septic patients. 2003

Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
Department of Critical Care Medicine, Erasme Hospital, Free University of Brussels, Belgium.

OBJECTIVE To investigate the relationship between red blood cell (RBC) shape and modifications of RBC membrane protein content in critically ill patients with or without sepsis compared with healthy control volunteers. METHODS Prospective, observational in vitro study. METHODS University-affiliated cell biology laboratory. METHODS Human erythrocytes from healthy volunteers and nonseptic and septic intensive care unit patients. METHODS Sialic acid membrane content was measured on isolated RBC membrane proteins by high-performance liquid chromatography. RBC shape, estimated by the spherical index (M2/M1) or by the moment and effect of osmolality on RBC shape, was studied by flow cytometry at 25 degrees C. Glycophorin A content was measured with antiglycophorin antibodies in flow cytometry. RESULTS Sialic acid content was lower in the septic than in the nonseptic patients (1.98 +/- 0.79, 2.20 +/- 0.39 microg/100 microg membrane protein, respectively; p =.01) and than in the volunteers (2.71 +/- 1.00 microg/100 microg membrane protein; p <.001). No significant difference was found in glycophorin A content between septic and nonseptic patients. RBCs from septic patients had a more spherical shape in isotonic solution than those of healthy volunteers, as assessed by a computed spherical index (M2/M1 ratio: 1.68 +/- 0.34 vs. 1.95 +/- 0.32; p =.001). Only the RBCs of septic patients failed to change their shape in hypo-osmolar solution (M2/M1 ratio: 1.68 +/- 0.34 in iso-osmolar, 1.56 +/- 0.28 in hypo-osmolar solution; p =.17). There was a significant correlation between the RBC shape evaluated by the spherical index or by the moment of the cytometric histogram and the sialic acid membrane content in all critically ill patients (septic and nonseptic patients) (r2 =.16, p =.01 for the moment, and r2 =.17, p =.01 for the spherical index, respectively). CONCLUSIONS RBCs of septic patients are characterized by a more spherical shape, a decreased capacity of sphericity in hypo-osmolar solution, and a reduction in the sialic acid content of the RBC membrane. These modifications in RBC shape and membrane may contribute to the RBC rheologic abnormalities frequently described in sepsis.

UI MeSH Term Description Entries
D008297 Male Males
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004907 Erythrocyte Deformability Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature. Erythrocyte Filterability,Deformability, Erythrocyte,Filterability, Erythrocyte
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006021 Glycophorins The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocyte Sialoglycoproteins,Glycoconnectin,Glycoconnectins,Glycophorin,Glycophorin D,MN Sialoglycoprotein,Red Blood Cell Membrane Sialoglycoprotein,Glycophorin A,Glycophorin A(M),Glycophorin B,Glycophorin C,Glycophorin E,Glycophorin HA,Ss Erythrocyte Membrane Sialoglycoproteins,Ss Sialoglycoprotein,beta-Sialoglycoprotein,Sialoglycoprotein, MN,Sialoglycoprotein, Ss,Sialoglycoproteins, Erythrocyte,beta Sialoglycoprotein

Related Publications

Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
July 2004, The Journal of trauma,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
January 1980, Acta haematologica,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
January 1978, The Italian journal of biochemistry,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
March 1961, Science (New York, N.Y.),
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
January 2017, Clinical hemorheology and microcirculation,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
October 1985, Carbohydrate research,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
June 1981, British journal of haematology,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
November 1979, The Journal of biological chemistry,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
July 1995, Journal of lipid research,
Michael Piagnerelli, and Karim Zouaoui Boudjeltia, and Danny Brohee, and Pietrina Piro, and Eric Carlier, and Jean-Louis Vincent, and Philippe Lejeune, and Michel Vanhaeverbeek
January 1978, Acta biologica Academiae Scientiarum Hungaricae,
Copied contents to your clipboard!